Polpharma Biologics Rebrands As New Warsaw Site Is Validated

First Production Run Expected In Mid-2021

 
• By Dean Rudge
Europe
Polpharma Biologics recently brought under its brand the Bioceros R&D site in Utrecht • Source: Shutterstock

More from Biosimilars

More from Products